Rhythm Pharmaceuticals, Inc. (RYTM) stock
RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30239% above fair value
$107.48−7.54 (-6.56%)
Close on Nov 16, 2026Market cap $7.40BP/E –Yield –
Rhythm Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Rhythm Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -85.6%. For fiscal 2025 it was -103.6%, against -200.3% the year before. The highest annual figure on record is -103.6% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -103.6% | +96.7 |
| FY2024 | Dec 31, 2024 | -200.3% | +38.2 |
| FY2023 | Dec 31, 2023 | -238.5% | +527.7 |
| FY2022 | Dec 31, 2022 | -766.2% | +1440.9 |
| FY2021 | Dec 31, 2021 | -2207.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -69.2% | +27.0 |
| Q1 FY2026 | Mar 31, 2026 | -92.6% | +58.8 |
| Q4 FY2025 | Dec 31, 2025 | -83.0% | +20.5 |
| Q3 FY2025 | Sep 30, 2025 | -103.1% | +28.1 |
| Q2 FY2025 | Jun 30, 2025 | -96.1% | +14.8 |
| Q1 FY2025 | Mar 31, 2025 | -151.4% | +393.1 |
| Q4 FY2024 | Dec 31, 2024 | -103.5% | +68.3 |
| Q3 FY2024 | Sep 30, 2024 | -131.2% | +65.0 |
| Q2 FY2024 | Jun 30, 2024 | -110.9% | +132.0 |
| Q1 FY2024 | Mar 31, 2024 | -544.4% | −89.5 |
| Q4 FY2023 | Dec 31, 2023 | -171.8% | +311.6 |
| Q3 FY2023 | Sep 30, 2023 | -196.2% | +757.6 |
| Q2 FY2023 | Jun 30, 2023 | -243.0% | +253.4 |
| Q1 FY2023 | Mar 31, 2023 | -455.0% | +3067.3 |
| Q4 FY2022 | Dec 31, 2022 | -483.4% | +1875.7 |
| Q3 FY2022 | Sep 30, 2022 | -953.8% | +2461.3 |
| Q2 FY2022 | Jun 30, 2022 | -496.4% | +12419.3 |
| Q1 FY2022 | Mar 31, 2022 | -3522.3% | −128522.3 |
| Q4 FY2021 | Dec 31, 2021 | -2359.2% | – |
| Q3 FY2021 | Sep 30, 2021 | -3415.1% | – |
| Q2 FY2021 | Jun 30, 2021 | -12915.7% | – |
| Q1 FY2021 | Mar 31, 2021 | 125000.0% | – |
See a number that looks wrong?